energy 发表于 2025-3-21 18:53:06

书目名称Resistant Hypertension in Chronic Kidney Disease影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0828471<br><br>        <br><br>书目名称Resistant Hypertension in Chronic Kidney Disease影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0828471<br><br>        <br><br>书目名称Resistant Hypertension in Chronic Kidney Disease网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0828471<br><br>        <br><br>书目名称Resistant Hypertension in Chronic Kidney Disease网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0828471<br><br>        <br><br>书目名称Resistant Hypertension in Chronic Kidney Disease被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0828471<br><br>        <br><br>书目名称Resistant Hypertension in Chronic Kidney Disease被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0828471<br><br>        <br><br>书目名称Resistant Hypertension in Chronic Kidney Disease年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0828471<br><br>        <br><br>书目名称Resistant Hypertension in Chronic Kidney Disease年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0828471<br><br>        <br><br>书目名称Resistant Hypertension in Chronic Kidney Disease读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0828471<br><br>        <br><br>书目名称Resistant Hypertension in Chronic Kidney Disease读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0828471<br><br>        <br><br>

讨好女人 发表于 2025-3-21 22:07:04

Book 2017 and resistant hypertension for general practitioners.  .Resistant Hypertension in CKD. brings up-to-date information to nephrologists, internists, cardiologists and a wide array of other clinicians and health professionals taking care of chronic kidney disease patients..

cancellous-bone 发表于 2025-3-22 04:23:13

http://reply.papertrans.cn/83/8285/828471/828471_3.png

Diverticulitis 发表于 2025-3-22 05:08:17

http://reply.papertrans.cn/83/8285/828471/828471_4.png

cancer 发表于 2025-3-22 08:48:20

Interference with Pharmacological Agents to Resistant Hypertension in Chronic Kidney Disease,endothelium-dependent vasodilation. In this chapter, we focus on the pharmacological interferences including appropriate diuretic therapy, aldosterone blockage, beta-blocker, and chronotherapy to deal with resistant hypertension in chronic kidney disease.

责任 发表于 2025-3-22 13:10:06

http://reply.papertrans.cn/83/8285/828471/828471_6.png

发表于 2025-3-22 18:29:00

http://reply.papertrans.cn/83/8285/828471/828471_7.png

Palpitation 发表于 2025-3-22 22:33:35

Devices for Neural Modulation (Renal Denervation, Barostimulation), antihypertensive therapy. Recently, two nonpharmacological interventional methods of antihypertensive treatment, renal denervation (RDN) and baroreceptor activation therapy (BAT), were introduced. Preliminary results concerning the use of both abovementioned methods in CKD patients suggest that RDN and BAT lowered the blood pressure.

fabricate 发表于 2025-3-23 02:03:08

Book 2017is separated into four parts; the first of which provides definitions, epidemiology, characteristics, risk stratification and outcomes of resistant and apparent treatment resistant hypertension.  The next two sections explore pathophysiology and diagnosis, treatment in the light of new guidelines, a

COUCH 发表于 2025-3-23 07:16:54

Definitions of Resistant Hypertension and Epidemiology of Resistant Hypertension,rials consistently demonstrate a significant health benefit from lowering blood pressure. Most hypertension can be controlled with lifestyle changes and antihypertensive agents. However, there remains a significant subgroup of patients with resistant hypertension that do not achieve optimal blood pr
页: [1] 2 3 4 5 6 7
查看完整版本: Titlebook: Resistant Hypertension in Chronic Kidney Disease; Adrian Covic,Mehmet Kanbay,Edgar V. Lerma Book 2017 Springer International Publishing AG